Equibles does not estimate personal net worth.
Get an email with a short summary when Idexx Laboratories Inc publishes a filing, an earnings call transcript or a press release.
Get IDXX alertsBrian McKeon is recorded as CFO at Idexx Laboratories Inc (IDXX). The newest filing on record that lists Brian McKeon as CFO at Idexx Laboratories Inc (IDXX) is dated March 27, 2026. Idexx Laboratories Inc reported in an 8-K filed November 21, 2024 that Brian McKeon retired as Executive Vice President, Chief Financial Officer and Treasurer, effective June 1, 2025. The proxy statement of Idexx Laboratories Inc reports total compensation of $351,680 for Brian McKeon in fiscal 2025, including a base salary of $293,404. Disclosed compensation is on record for 9 fiscal years. Brian McKeon has spoken on 20 earnings calls across 1 company, most recently for Idexx Laboratories Inc on February 3, 2025. Idexx Laboratories Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Idexx Laboratories Inc includes Jonathan Mazelsky (CEO), Michael (Mike) Erickson (CEO and Board Member), Michael (Mike) Erickson, PhD (CEO and Board Member) and 7 others.
“On November 20, 2024, Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer of IDEXX Laboratories, Inc. (the “Company” or “IDEXX”) notified the Company that he will retire from IDEXX effective June 1, 2025.”
“Today, I'm pleased to review our Q4 and full year 2024 financial results. Andrew Emerson, who will be assuming responsibility as IDEXX's CFO on March 1st, will take you through the details of the company's outlook for 2025.”
“Today I'll take you through our Q3 results and review our updated financial outlook for 2024. IDEXX delivered solid organic revenue growth and strong comparable profit gains in the third quarter.”
“Today, I'll take you through our Q2 results and review our updated financial outlook for 2024. IDEXX delivered solid organic revenue growth and strong comparable profit gains in the second quarter.”
“Today, I'll take you through our Q1 results and review our updated financial outlook for 2024. In terms of highlights, IDEXX achieved solid organic revenue growth and strong profit gains in the first quarter.”
“I'm pleased to take you through our fourth quarter and full year 2023 results and to provide an overview of our financial outlook for 2024. IDEXX had a strong finish to 2023, reflected in our fourth quarter performance.”
Start not stated–present
Last confirmed March 27, 2026
Start not stated–2025-06-01
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Idexx Laboratories Inc (IDXX) | Former Executive Vice President, Chief Financial Officer and Treasurer | $293,404 | $351,680 |
| 2024 | Idexx Laboratories Inc (IDXX) | Executive Vice President and Special Advisor (Former Chief Financial Officer and Treasurer) | $689,558 | $3,892,748 |
| 2023 | Idexx Laboratories Inc (IDXX) | Executive Vice President and Special Advisor (Former Chief Financial Officer and Treasurer) | $669,023 | $3,845,065 |
| 2022 | Idexx Laboratories Inc (IDXX) | Executive Vice President and Special Advisor (Former Chief Financial Officer and Treasurer) | $644,249 | $3,510,826 |
| 2021 | Idexx Laboratories Inc (IDXX) | Executive Vice President, Chief Financial Officer and Treasurer | $625,485 | $3,625,035 |
| 2020 | Idexx Laboratories Inc (IDXX) | Executive Vice President, Chief Financial Officer and Treasurer | $597,202 | $3,350,185 |
| 2019 | Idexx Laboratories Inc (IDXX) | Executive Vice President, Chief Financial Officer and Treasurer | $588,933 | $3,940,306 |
| 2018 | Idexx Laboratories Inc (IDXX) | Executive Vice President, Chief Financial Officer and Treasurer | $570,577 | $2,905,934 |
| 2017 | Idexx Laboratories Inc (IDXX) | Executive Vice President, Chief Financial Officer and Treasurer | $549,538 | $2,422,971 |
